Health CanadaType III
Rivasa 81 mg EC tablet; Out of specification (salicylic acid impurity)
Published: June 6, 2025Recall ID: 77564Category: generalCountry: Canada
Reason for Recall / Hazard
Product quality
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
RIVASA 81mg EC tablet
Additional Source Details
| Field | Value |
|---|---|
| N I D | 77564 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/rivasa-81-mg-ec-tablet-out-specification-salicylic-acid-impurity |
| Issue | Product quality |
| Title | Rivasa 81 mg EC tablet; Out of specification (salicylic acid impurity) |
| Product | RIVASA 81mg EC tablet |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2025-06-06 |
| Organization | Drugs and health products |
| Recall class | Type III |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |